Frederiksberg, Denmark

Andreas Petri

USPTO Granted Patents = 6 


Average Co-Inventor Count = 4.6

ph-index = 1


Location History:

  • Frederiksberg C, DK (2020)
  • Frederiksberg, DK (2019 - 2022)
  • Aalborg, DK (2022)

Company Filing History:


Years Active: 2019-2024

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Andreas Petri

Introduction

Andreas Petri is a notable inventor based in Frederiksberg, Denmark. He has made significant contributions to the field of medical research, particularly in cancer treatment. With a total of 6 patents, his work focuses on innovative methods that target specific biological mechanisms.

Latest Patents

One of his latest patents is titled "Targeting Human Satellite II (HSATII)." This patent outlines methods for treating cancer, specifically cancers of epithelial origin, by targeting human satellite II using sequence-specific agents such as oligonucleotides. Another important patent is "Inhibitors of Micro-RNA 22," which provides compositions and methods that inhibit the activity of microRNAs, including miR-22. These patents reflect his commitment to advancing cancer therapies through targeted approaches.

Career Highlights

Throughout his career, Andreas Petri has worked with esteemed institutions such as Aalborg University and The General Hospital Corporation. His research has contributed to the understanding and treatment of complex medical conditions, showcasing his expertise in the field.

Collaborations

Andreas has collaborated with notable colleagues, including Sakari Kauppinen and Anders M Naar. These partnerships have further enhanced his research and innovation efforts.

Conclusion

Andreas Petri's work exemplifies the impact of innovative thinking in medical research. His patents and collaborations highlight his dedication to improving cancer treatment methodologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…